RT Journal Article
SR Electronic
T1 Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng <em>et al</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005086
DO 10.1136/jitc-2022-005086
VO 10
IS 5
A1 Viswanathan, Vidya Sankar
A1 Khorrami, Mohammadhadi
A1 Jazieh, Khalid
A1 Fu, Pingfu
A1 Pennell, Nathan
A1 Madabhushi, Anant
YR 2022
UL http://jitc.bmj.com/content/10/5/e005086.abstract